CENTRAL VERMONT HOSPITAL
1. Target Overview & Investment Thesis
CENTRAL VERMONT HOSPITAL is a 88-bed suburban community hospital in WASHINGTON, VT with $271.0M in net patient revenue and a -2.6% operating margin. The hospital serves a payer mix of 57.0% Medicare, 22.9% Medicaid, and 20.1% commercial.
Thesis: Turnaround. Our ML models identify $19.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.6% to 4.7% (+736bps).
| Net Revenue HCRIS | $271.0M |
| Current EBITDA COMPUTED | $-7.1M |
| Operating Margin COMPUTED | -2.6% |
| Occupancy HCRIS | 69.5% |
| Revenue / Bed COMPUTED | $3.1M |
| Net-to-Gross HCRIS | 49.3% |
| Distress Probability ML | 48.9% |
2. Market Context & Competitive Position
VT has 16 Medicare-certified hospitals with a median operating margin of -26.6%. The target's margin of -2.6% places it above the state median. Among 2164 size-comparable peers (44-176 beds), the median margin is -3.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (44-176), prioritizing same-state peers. 2164 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CENTRAL VERMONT HOSPITAL (Target) | VT | 88 | $271.0M | -2.6% |
| MIDWESTERN REGIONAL MEDICAL CE | IL | 73 | $1.38B | 80.5% |
| ROSWELL PARK CANCER INSTITUTE | NY | 142 | $772.3M | -40.1% |
| CHILDRENS HOSP & RES CNTR OAKL | CA | 155 | $687.9M | -7.1% |
| ROUND ROCK HOSPITAL | TX | 165 | $681.4M | 8.7% |
| BELLIN MEMORIAL HOSPITAL | WI | 175 | $652.3M | 13.7% |
| CONTRA COSTA REGIONAL MEDICAL | CA | 124 | $595.0M | -29.2% |
| JOHN DEMPSEY HOSPITAL | CT | 141 | $590.3M | -24.8% |
| MERCY MEDICAL CENTER | MD | 173 | $561.3M | -3.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $19.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $5.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $5.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $5.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $3.3M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $173K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-7.1M |
| + RCM Uplift | +$19.9M |
| Pro Forma EBITDA | $12.8M |
| Current Margin | -2.6% |
| Pro Forma Margin | 4.7% |
| WC Released (1x) | $10.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-11.0M | $152.3M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-11.0M | $164.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-9.9M | $226.3M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-9.9M | $243.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-12.1M | $56.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-12.1M | $57.9M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Heavy Medicare dependence | Medicare comprises 57.0% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
| Medium | Elevated Medicaid exposure (22.9%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 2164 hospitals with 44-176 beds
- Same-state prioritization (n=6)
- Comp margins: P25=-15.2% / P50=-3.2% / P75=8.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.